Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity
- 1 January 1982
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 99 (1) , 150-160
- https://doi.org/10.1530/acta.0.0990150
Abstract
: DNA, RNA and protein content of the liver, kidneys and spleen were studied in dwarf mice during treatment with human growth hormone (hGH), thyroxine and plasma fractions containing somatomedin activity (SM-P1 and SM-P4). This investigation has revealed that part of the growth of the liver and all growth of the spleen obtained with the administered preparations, are a consequence of nuclear division. Cell enlargement is not induced in the spleen by either of the preparations used. In the liver a small degree of hypertrophy is obtained with SM-P1. In the kidney both cell number and cell size are stimulated by thyroxine and to a lesser extent by hGH and SM-P1. With regards to the RNA content per cell an increase is obtained with hGH and thyroxine in the liver and in the kidneys also with SM-P1, but not in the spleen. These data demonstrate that semi-purified SM-preparations, like hGH and thyroxine, might be potent stimuli for the restoration of the impaired nucleic acid metabolism in these organs of the Snell dwarf mouse.Keywords
This publication has 0 references indexed in Scilit: